Ireland· IE-PA-EU/1/10/647/003-004
Myclausen 500 mg film-coated tablets
A mycophenolic acid product containing mycophenolate mofetil, registered in Ireland by Herbert J. Passauer GmbH & Co. KG. The same ATC class is registered in 15 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Mycophenolic acid is registered in 15 of 19 countries.
Countries holding a registration under ATC L04AA06 (mycophenolic acid), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Mycophenolic acid · ATC L04AA06
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mycophenolic acid costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mycophenolic acid · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.57
- IT Italy$8.14
The record
At a glance
HPRA (Ireland)- Active substance
- Mycophenolate mofetil
- Manufacturer
- Herbert J. Passauer GmbH & Co. KG
- Country
- Ireland (IE)
- ATC code
- L04AA06
- ATC class
- Mycophenolic acid
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/10/647/003-004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
350 interactions on record for mycophenolic acid.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mycophenolic acid · interactions on record
350 records
- 50 severe
- 179 moderate
- 20 minor
- 75 info
Most severe, free to view
- Medicinal charcoalA07BA01severe
- ColestyramineC10AC01severe
- ColestipolC10AC02severe
- ColesevelamC10AC04severe
26 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mycophenolic acid in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCellCeptGenentech, Inc.
- United KingdomArzip 250mg capsulesZentiva Pharma UK Ltd
- CzechiaCELLCEPTRoche Registration GmbH, Grenzach-Wyhlen
- FinlandCellceptRoche Registration GmbH
- SwedenCellCept 1 g/5 ml Pulver till oral suspensionRoche Registration GmbH
- BelgiumCellcept 1 g/5 mlRoche Registration
- CanadaACH-MYCOPHENOLATEACCORD HEALTHCARE INC
- FranceCELLCEPT 1 g/5 mL, poudre pour suspension buvableROCHE REGISTRATION (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Mowel, Mycophenolat Mofetil Sandoz
- Belgium · Mycophenolat Mofetil Sandoz
- Bulgaria · Микофенолат Мофетил Акорд
- Czechia · Mycophenolat Mofetil Sandoz
- Germany · Mowel, Mycophenolat 1 A Pharma
- Denmark · Mycophenolate Mofetil Hexal, Mycophenolatmofetil Accord
- Estonia · Mycophenolate Mofetil Accord
- Spain · Micofenolato De Mofetilo Accord, Micofenolato De Mofetilo Aristo
- Finland · Mycophenolate Mofetil Accord, Mycophenolate Mofetil Eql Pharma
- France · Mycophenolate Mofetil Arrow, Mycophenolate Mofetil Biogaran
- United Kingdom (Northern Ireland) · Mycophenolate Hexal, Mycophenolate Mofetil
- Croatia · Mofetilmikofenolat Tillomed, Trixin
- Iceland · Cellcept, Myclausen
- Italy · Micofenolato Mofetile Accord, Micofenolato Mofetile Ahcl
- Liechtenstein · Cellcept, Myclausen
- Lithuania · Mycophenolate Mofetil Accord
- Latvia · Mycophenolate Mofetil Accord
- Malta · Mycophenolate Mofetil Ascend
- Netherlands · Mycofenolaat Mofetil Accord, Mycofenolaat Mofetil Sandoz
- Norway · Cellcept, Myclausen
- Poland · Mycofit, Mycophenolate Mofetil Sandoz
- Portugal · Micofenolato De Mofetil Accord, Micofenolato De Mofetil Aristo
- Romania · Micofenolat Mofetil Sandoz
- Sweden · Mycophenolate Mofetil Accord, Mycophenolate Mofetil Eql Pharma
- Slovakia · Mykofenolát Mofetil Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f98ddc57-3c58-4f44-bd99-20ac5c15cf70 GET /v1/drugs/f98ddc57-3c58-4f44-bd99-20ac5c15cf70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L04AA",
"L04AA06"
],
"strength": null,
"pa_number": "EU/1/10/647/003-004",
"substances": [
"Mycophenolate mofetil"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about mycophenolic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.